Doreen Brettler to Clinical Trials as Topic
This is a "connection" page, showing publications Doreen Brettler has written about Clinical Trials as Topic.
Connection Strength
0.133
-
Brettler DB. A recombinant circumsporozoite protein vaccine against malaria. N Engl J Med. 1997 Jun 12; 336(24):1759; author reply 1760-1.
Score: 0.112
-
Brettler DB. Proposed protocol for the evaluation of the effect of high purity factor concentrates on the immune system of hemophilia patients. Thromb Haemost. 1989 Sep 29; 62(2):811-2.
Score: 0.016
-
Mannucci PM, Schimpf K, Brettler DB, Ciavarella N, Colombo M, Haschke F, Lechner K, Lusher J, Weissbach G. Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group. Ann Intern Med. 1990 Jul 01; 113(1):27-32.
Score: 0.004